Related Experiment Video

Updated: Jul 10, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer

Fan Cheng1, Ian S Zagon, Michael F Verderame

  • 1Department of Neural and Behavioral Sciences, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

Cancer Research
|November 3, 2007
PubMed

Insights

The opioid growth factor (OGF) inhibits head and neck squamous cell carcinoma (HNSCC) growth by targeting the p16 protein pathway. This discovery offers new avenues for HNSCC diagnosis and treatment.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is a significant global health concern, accounting for 5.5% of worldwide malignancies.
  • The opioid growth factor (OGF) and its receptor (OGFr) constitute an endogenous system that regulates cell growth, particularly influencing the G(0)-G(1) phase of the cell cycle in HNSCC.

Purpose of the Study:

  • To elucidate the precise molecular target through which OGF exerts its cell cycle inhibitory effects in HNSCC.
  • To investigate the role of the OGF-OGFr axis in regulating key cell cycle proteins and pathways within HNSCC.

Main Methods:

  • Utilized SCC-1, CAL-27, and SCC-4 HNSCC cell lines.
  • Employed small interfering RNA (siRNA) to inhibit OGFr and p16 (INK4a) expression.
  • Assessed protein phosphorylation, kinase activity (Cdk4, Cdk2), protein expression (p16), and protein complex formation (p16-Cdk4).
  • Investigated the effects of OGF, naloxone, and p16 inhibition on cell proliferation.

Main Results:

  • OGF treatment decreased retinoblastoma protein phosphorylation and Cdk4 kinase activity, but not Cdk2.
  • OGF significantly increased p16 protein expression, which then complexed with Cdk4.
  • Blockade of OGF-OGFr interaction with naloxone abolished OGF-induced p16 expression.
  • Inhibition of p16 activation using siRNA abrogated OGF's growth-inhibitory effects on multiple HNSCC cell lines.

Conclusions:

  • The OGF-OGFr axis inhibits HNSCC cell proliferation by targeting the cyclin-dependent kinase inhibitor p16 pathway.
  • These findings reveal a novel mechanism of OGF action in HNSCC and suggest potential therapeutic applications for targeting this pathway in cancer treatment.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...